2020 annual financial data
Relmada Therapeutics, Inc. 2020 Operating margin
Relmada Therapeutics, Inc. 2020 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -60,838,673 USD and net income was -59,456,394 USD.
Operating cash flow was -27,808,801 USD.
Get free Relmada Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -60,838,673 USD
- Net income
- -59,456,394 USD
- Operating cash flow
- -27,808,801 USD
Explore related company data
View all 2020 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Relmada Therapeutics, Inc. financial years